The world's most recognisable and successful pharmaceutical companies rely on Lanner's predictive simulation technology and expertise to improve their business planning cycles and decision making across:
- Capital investments - through accurate modelling of proposed new capabilities/capacities costs can be justified or avoided.
- Operating costs and inventory - through accurate modelling of the subtle and often complex interactions between equipment utilisation, labour, product mix and demand variability and materials the right balance of performance and costs can streamline inventory and reduce operating costs.
- Delivery performance assurance - through more effective use of existing assets, lower cost to serve and better plan adherence through accurate modelling of capability and capacity impacts of product and plant transfers.
- Responsiveness to market and revenue potential - assisting NPI through accurate assessment of existing capacity and operations, whether at plant, value chain or network strategy level.